Takeshi Saito

Minato, 1050003, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Journal: International journal of clinical oncology

Published: April 11, 2026

Bronchiolitis obliterans complicating follicular lymphoma: a case series and clinical insights.

Bronchiolitis obliterans complicating follicular lymphoma: a case series and clinical insights.

Journal: International journal of hematology

Published: August 22, 2025

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Journal: International journal of hematology

Published: August 09, 2025

Area under tacrolimus concentrations predict outcomes after unrelated allogeneic hematopoietic stem cell transplantation.

Area under tacrolimus concentrations predict outcomes after unrelated allogeneic hematopoietic stem cell transplantation.

Journal: International journal of hematology

Published: April 22, 2025

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Journal: Cancers

Published: November 27, 2024

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Journal: International journal of hematology

Published: September 06, 2024

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation.

A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation.

Journal: International journal of hematology

Published: July 30, 2024

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Journal: Cancer science

Published: July 11, 2024

Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort.

Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort.

Journal: International journal of hematology

Published: February 16, 2024

Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.

Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.

Journal: Internal medicine (Tokyo, Japan)

Published: August 09, 2023

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Journal: International journal of hematology

Published: July 25, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026